Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-12-18
|
pubmed:abstractText |
The association of verapamil with halothane causes ischaemic-like myocardial dysfunction. Using an isolated rat heart model perfused with a radiolabelled fatty acid (123I-labelled iodohexadecenoic acid) as a sensitive marker of ischaemia this study investigated whether or not this dysfunction is of ischaemic origin. Hearts were perfused with a control solution or with solutions containing either 1% of halothane or 150 ng ml-1 of verapamil or the association of 0.75% halothane + 120 ng ml-1 verapamil. The ischaemic group was perfused at a reduced perfusion rate (-50%). Intracellular fate of IHA was assessed, and its esterification ratio computed. Ischaemia and the drugs induced a similar depression of haemodynamics. The esterification ratio in the ischaemic group was significantly higher (0.723 +/- 0.04) than in controls (0.0526 +/- 0.03) and than in the treated groups: halothane (0.533 +/- 0.06), verapamil (0.411 +/- 0.027) or the association halothane+verapamil (0.408 +/- 0.05), suggesting a non-ischaemic origin for the dysfunction caused by halothane-verapamil.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/16-iodo-9-hexadecenoic acid,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Halothane,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Palmitic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Verapamil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0265-0215
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
447-55
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1425613-Animals,
pubmed-meshheading:1425613-Blood Pressure,
pubmed-meshheading:1425613-Drug Combinations,
pubmed-meshheading:1425613-Halothane,
pubmed-meshheading:1425613-Heart Rate,
pubmed-meshheading:1425613-Iodine Radioisotopes,
pubmed-meshheading:1425613-Lipids,
pubmed-meshheading:1425613-Male,
pubmed-meshheading:1425613-Myocardial Ischemia,
pubmed-meshheading:1425613-Myocardium,
pubmed-meshheading:1425613-Oxidation-Reduction,
pubmed-meshheading:1425613-Palmitic Acids,
pubmed-meshheading:1425613-Perfusion,
pubmed-meshheading:1425613-Rats,
pubmed-meshheading:1425613-Rats, Wistar,
pubmed-meshheading:1425613-Ventricular Function, Left,
pubmed-meshheading:1425613-Verapamil
|
pubmed:year |
1992
|
pubmed:articleTitle |
Comparative effects of halothane associated with verapamil and ischaemia on myocardial metabolism in isolated perfused rat hearts.
|
pubmed:affiliation |
Département d'Anesthésie Réanimation, Université J. Fourier, C.H.U de Grenoble, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|